法巴健康護理創新股票基金 I (歐元)

1721.90歐元22.76(1.34%)
2023/12/01更新
績效 / 
1月2.5%
3月4.42%
1年9.55%
晨星評等
資產分佈
  1. 1.現金1.27%
  2. 2.股票21.60%
  3. 3.債券0.00%
  4. 4.其他77.13%
前五大投資區域
  1. 1.美國77.13%
  2. 2.英國7.62%
  3. 3.歐洲不包含歐元區7.53%
  4. 4.歐元區6.01%
  5. 5.加拿大0.44%
前十大行業比重
  1. 1.健康護理98.73%
前十大持股
  1. 1.UnitedHealth Group Inc9.36%
  2. 2.Eli Lilly and Co8.71%
  3. 3.AstraZeneca PLC7.05%
  4. 4.Sanofi SA5.33%
  5. 5.Boston Scientific Corp4.90%
  6. 6.Bristol-Myers Squibb Co4.37%
  7. 7.Thermo Fisher Scientific Inc4.13%
  8. 8.Jazz Pharmaceuticals PLC3.93%
  9. 9.Vertex Pharmaceuticals Inc3.69%
  10. 10.Neurocrine Biosciences Inc3.68%
其他:包括其他持股、債券、現金與其他投資標的
資產分佈
  1. 1.現金1.27%
  2. 2.股票21.60%
  3. 3.債券0.00%
  4. 4.其他77.13%
前十大行業比重
  1. 1.健康護理98.73%
前五大投資區域
  1. 1.美國77.13%
  2. 2.英國7.62%
  3. 3.歐洲不包含歐元區7.53%
  4. 4.歐元區6.01%
  5. 5.加拿大0.44%
前十大持股
  1. 1.UnitedHealth Group Inc9.36%
  2. 2.Eli Lilly and Co8.71%
  3. 3.AstraZeneca PLC7.05%
  4. 4.Sanofi SA5.33%
  5. 5.Boston Scientific Corp4.90%
  6. 6.Bristol-Myers Squibb Co4.37%
  7. 7.Thermo Fisher Scientific Inc4.13%
  8. 8.Jazz Pharmaceuticals PLC3.93%
  9. 9.Vertex Pharmaceuticals Inc3.69%
  10. 10.Neurocrine Biosciences Inc3.68%
其他:包括其他持股、債券、現金與其他投資標的